This session will describe the role of the Clinical Investigator Collaborative in the development of new therapies for treating asthma.
Session moderator: Dr. Paul O’Byrne
Understanding drug targets – what the CIC has achieved to date
Speaker: Dr. Gail Gauvreau
Contributions of CIC to testing of drug targets and the development of new therapies.
New pathways of allergic airway disease uncovered using CIC models of asthma.
Speaker: Dr. Scott Tebbutt
Application of novel scientific tools for
mapping mechanisms of disease in CIC cohorts.
Benefits of partnership with the CIC – the role of
clinical models in drug development
Speaker: Dr. Paul Newbold
How data from CIC studies are used by
industry for drug development.
Overview of SA-CIC and potential impacts
Speaker: Dr. Parameswaran Nair
Overview of SA-CIC sub-studies and impact
on identification of treatment strategies.